NAS:XLRN (USA) Also Trade In: Germany
Acceleron Pharma Inc $ 112.53 -0.58 (-0.51%)
Warning! GuruFocus has detected 4 Severe warning signs with XLRN. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Acceleron Pharma Inc () from 2013 to Oct 01 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Acceleron Pharma stock (XLRN) PE ratio as of Oct 01 2020 is 0. More Details
Acceleron Pharma PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Acceleron Pharma PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:RETA NAS:UTHR NAS:MYOK NAS:ZLAB NAS:ADPT NAS:IOVA NAS:JAZZ NAS:ALLO NAS:MRTX NAS:FTSV OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 128 Sidney Street, Cambridge, MA, USA, 02139
Acceleron Pharma is a biotechnology company focused on the discovery, development, and commercialization of novel therapies. The company's research focuses on key natural regulators of cellular growth and repair. Acceleron generates its revenue through collaboration, licensing, and research arrangements with collaboration partners for the development and commercialization of therapeutic candidates. The company sometimes uses contract research organizations and research institutions outside the United States.